Mifcare;INSERM (Institut National de la Santé et de la Recherche Médicale);Université Paris Sud 11
发明人:
申请号：
EP14168742.6
公开号：
EP2944310B1
申请日:
2014.05.16
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to the use of compounds of general formula I: and pharmaceutically acceptable enantiomers, salts or solvates thereof, for treating pulmonary hypertension in a subject.
